Aurora Cannabis: Analysts Slash Price Targets Ahead Of Q4 Earnings
Tomorrow after market close Aurora Cannabis (TSX: ACB) (NYSE: ACB) will be reporting their fiscal fourth quarter financials for the
Read more
Aurora Cannabis
Aurora Cannabis: “Material Weaknesses” Exist In Firms Internal Control Framework
Aurora Cannabis (TSX: ACB) (NYSE: ACB) this morning issued a press release identifying that it would be releasing its fourth
Read more
Aurora Cannabis: Stifel Lowers Rating To Hold, Price Target Falls To $10.50 From $16
Yesterday, Aurora Cannabis (TSX: ACB) (NYSE: ACB) provided a business update. The firm announced that they have found a permanent
Read more
Aurora Cannabis Names New CEO, Announces Over $1.8 Billion In Q4 Writedowns On Declining Revenues
Aurora Cannabis (TSX: ACB) (NYSE: ACB) this morning finally announced their new CEO, whom as it turns out was an
Read more
Aurora Cannabis Sued By CTT Pharma Over Denial Of Contractual Commitments
It seems Aurora Cannabis (TSX: ACB) (NYSE: ACB) has found itself in some hot water. It was announced this morning
Read more
High Tide Sees $10.8 Million Debt Extension By “Industry Investor” Believed To Be Aurora Cannabis
High Tide Inc (CSE: HITI) has managed to bolster its balance sheet as of this morning, with the announcement that
Read more
Aurora Cannabis, Aphria Said To Have Walked From Potential Merger Over Executive Compensation
It’s been reported by BNN Bloomberg that Aphria Inc (TSX: APHA) (NASDAQ: APHA) and Aurora Cannabis (TSX: ACB) (NYSE: ACB)
Read more
Aurora Cannabis Sees Co-Founder Terry Booth Resign From Board
Ex-CEO of Aurora Cannabis (TSX: ACB) (NYSE: ACB) Terry Booth has officially left the building. This morning, Aurora announced that
Read more
Aurora Cannabis To Shutter Five Facilities, Faces Impairments of $200 Million
Aurora Cannabis (TSX: ACB) (NYSE: ACB) this morning released an update in relation to its ongoing business transformation plan. The
Read more
Aurora Cannabis: The Analysts Take On The Reliva Acquisition
A week after Aurora Cannabis (TSX: ACB) (NYSE: ACB) closed their U$40 million all-share deal for U.S. hemp operator Reliva,
Read more